Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GlaxoSmithKline Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 124.33B | 14.8x | 0.01 | PKR 390.40 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbott Laboratories Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 95.45B | 15x | 0.11 | PKR 975 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Haleon Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 84.61B | 15.4x | 0.05 | PKR 722.84 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGP | Karachi | Healthcare | Pharmaceuticals | PKR 53.24B | 16.4x | 0.19 | PKR 190.14 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
Highnoon Labs | Karachi | Healthcare | Pharmaceuticals | PKR 52B | 13.7x | 0.44 | PKR 981.47 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Searle Company | Karachi | Healthcare | Pharmaceuticals | PKR 44.49B | 20.8x | -0.24 | PKR 86.99 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.8% Upside | Upgrade to Pro+ | |
Hoechst Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 31.66B | 15.8x | 0.16 | PKR 3,282.70 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shifa International Hospitals | Karachi | Healthcare | Healthcare Providers & Services | PKR 29.65B | 13.1x | 0.14 | PKR 469 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macter International | Karachi | Healthcare | Pharmaceuticals | PKR 23.35B | PKR 509.76 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Citi Pharma | Karachi | Healthcare | Pharmaceuticals | PKR 19.19B | 22.4x | 7.61 | PKR 84 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ferozsons Labs | Karachi | Healthcare | Pharmaceuticals | PKR 16.64B | 18.7x | 0.42 | PKR 382.70 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BF Biosciences | Karachi | Healthcare | Pharmaceuticals | PKR 14.93B | 34.6x | -3.64 | PKR 169 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.2% Downside | Upgrade to Pro+ | |
Liven Pharma | Karachi | Healthcare | Pharmaceuticals | PKR 6.25B | 36x | 0.19 | PKR 67.20 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Otsuka Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 3.54B | 114.9x | -1.8 | PKR 292.79 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |